Investors
We maintain a transparent, comprehensive dialogue with the financial community about our strategy, outlook, financial data, economic environment, and social impact.
Second Quarter 2026 Results
Second quarter 2026 results were reviewed by management during a live audio webcast with the financial community on July 30, 2026. The presentation was followed by a Q&A session.
Press Releases
Upcoming Events
17Sep
BNP Paribas Sustainability Conference – Paris
Speaker : Laurent Lhopitallier, Head of ESG Performances
Conferences
22Sep
Bank of America Global Healthcare Conference - London
Speaker : Mike Quigley, Chief Scientific Officer
Conferences
23Sep
UBS Pharma Bus Tour – Paris
Speakers : Belén Garijo, CEO & Mike Quigley, Chief Scientific Officer
Conferences
Dividend (in dollars) per ADR (½ share)
Environment, Social, Governance
As a global pharmaceutical company, we stretch everyday to deliver safe and sustainable innovation and play our part in addressing some of the world’s most pressing challenges.
Contact Our Investor Relations Team
For general inquiries
Please contact the switchboard, +33 (0)1 53 77 40 00